Efficacy and safety of intracoronary prourokinase during percutaneous coronary intervention in treating ST-segment elevation myocardial infarction patients: a randomized, controlled study

BACKGROUND: Prourokinase is a single-chain plasminogen activator presenting with fewer hemorrhagic complications and reduced reocclusion rate compared with the conventional fibrinolytic agents in patients with coronary artery disease. However, prourokinase intracoronary injection during PCI for trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yanqiang, Fu, Xianghua, Feng, Qiang, Gu, Xinshun, Hao, Guozhen, Fan, Weize, Jiang, Yunfa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318521/
https://www.ncbi.nlm.nih.gov/pubmed/32590944
http://dx.doi.org/10.1186/s12872-020-01584-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318521/
https://www.ncbi.nlm.nih.gov/pubmed/32590944
http://dx.doi.org/10.1186/s12872-020-01584-0

Ejemplares similares